Lista de obras -

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses ⬇️

artículo científico publicado en 2009

A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.

artículo científico publicado en 2009

A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer

artículo científico publicado en 2014

Advances in gene therapy for malignant melanoma

artículo científico publicado en 2002

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen

artículo científico publicado en 2005

Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity

artículo científico publicado en 2008

Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal

artículo científico publicado en 2020

Cancer immunotherapy comes of age

artículo científico publicado en 2011

Cellular immune selection with hepatitis C virus persistence in humans

artículo científico publicado en 2005

Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade

artículo científico publicado en 2014

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

artículo científico publicado en 2012

Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

artículo científico publicado en 2005

Concepts of immunotherapy for glioma

artículo científico publicado en 2015

Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells

artículo científico publicado en 2005

Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 ⬇️

artículo científico publicado el 25 de agosto de 2011

Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

article

Cutting edge: Expression of functional CD137 receptor by dendritic cells

artículo científico publicado en 2002

Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade

artículo científico publicado en 2015

Differential binding properties of B7-H1 and B7-DC to programmed death-1

artículo científico publicado en 2003

Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells

artículo científico publicado en 2009

Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis

artículo científico publicado en 2006

Expression of programmed death 1 ligands by murine T cells and APC

artículo científico publicado en 2002

Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model

artículo científico publicado en 2014

Glycolipid Antigens for Treating Hepatic Colorectal Cancer Metastases and Their Effect on the Therapeutic Efficacy of Live Attenuated Listeria monocytogenes ⬇️

artículo científico publicado el 1 de mayo de 2012

HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon

artículo científico publicado en 2014

Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire

artículo científico publicado en 2008

High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection

artículo científico publicado en 2008

Immune checkpoint blockade: a common denominator approach to cancer therapy

artículo científico publicado en 2015

Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape

artículo científico publicado en 2011

Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease

artículo científico publicado en 2005

Inhibition of activation-induced death of dendritic cells and enhancement of vaccine efficacy via blockade of MINOR

scientific journal article

Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats

scientific journal article

Interleukin 17 and senescent cells regulate the foreign body response to synthetic material implants in mice and humans

scientific article published on 01 April 2020

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

artículo científico publicado en 2016

Mechanisms regulating PD-L1 expression on tumor and immune cells

scientific article published on 15 November 2019

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Microbiota organization is a distinct feature of proximal colorectal cancers ⬇️

artículo científico publicado en 2014

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

artículo científico publicado en 2017

Neoadjuvant checkpoint blockade for cancer immunotherapy

artículo científico publicado en 2020

Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia

artículo científico publicado en 2014

Opportunities and Challenges in the Development of Experimental Drug Combinations for Cancer ⬇️

artículo científico publicado el 15 de julio de 2011

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

artículo científico publicado en 2015

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

artículo científico publicado en 2015

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

artículo científico publicado en 2016

PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment

artículo científico publicado en 2014

Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

article

Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors

artículo científico publicado en 2009

Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability

artículo científico publicado en 2007

Role of LAG-3 in regulatory T cells.

artículo científico publicado en 2004

Role of Stat3 in regulating p53 expression and function

artículo científico publicado en 2005

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

artículo científico publicado en 2012

Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting

artículo científico publicado en 2015

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer ⬇️

artículo científico publicado el 2 de junio de 2012

Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype

artículo científico publicado en 2005

Stat3 activation in murine colitis induced by enterotoxigenic Bacteroides fragilis

artículo científico publicado en 2014

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens

artículo científico publicado en 2021

Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab

artículo científico publicado en 2015

T cells take aim at cancer

artículo científico publicado en 2002

TCR β chain-directed bispecific antibodies for the treatment of T cell cancers

artículo científico publicado en 2021

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity ⬇️

artículo científico publicado el 9 de enero de 2012

Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy

artículo científico publicado en 2017

The Immunosuppressive Niche of Soft Tissue Sarcomas is Sustained by Tumor Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures

scientific article published on 24 April 2020

The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell Carcinoma

artículo científico publicado en 2016

The blockade of immune checkpoints in cancer immunotherapy ⬇️

artículo científico publicado el 22 de marzo de 2012

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3

scientific journal article

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints

artículo científico publicado en 2014

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints

Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy.

artículo científico publicado en 2017

Treg functional stability and its responsiveness to the microenvironment

artículo científico publicado en 2014

Ubiquitin-dependent regulation of Foxp3 and Treg function

artículo científico publicado en 2015

Lista de obras de

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses ⬇️

A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.

A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer

Advances in gene therapy for malignant melanoma

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen

Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity

Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal

Cancer immunotherapy comes of age

Cellular immune selection with hepatitis C virus persistence in humans

Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

Concepts of immunotherapy for glioma

Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells

Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 ⬇️

Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

Cutting edge: Expression of functional CD137 receptor by dendritic cells

Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade

Differential binding properties of B7-H1 and B7-DC to programmed death-1

Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells

Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis

Expression of programmed death 1 ligands by murine T cells and APC

Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model

Glycolipid Antigens for Treating Hepatic Colorectal Cancer Metastases and Their Effect on the Therapeutic Efficacy of Live Attenuated Listeria monocytogenes ⬇️

HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon

Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire

High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection

Immune checkpoint blockade: a common denominator approach to cancer therapy

Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape

Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease

Inhibition of activation-induced death of dendritic cells and enhancement of vaccine efficacy via blockade of MINOR

Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats

Interleukin 17 and senescent cells regulate the foreign body response to synthetic material implants in mice and humans

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

Mechanisms regulating PD-L1 expression on tumor and immune cells

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

Microbiota organization is a distinct feature of proximal colorectal cancers ⬇️

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

Neoadjuvant checkpoint blockade for cancer immunotherapy

Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia

Opportunities and Challenges in the Development of Experimental Drug Combinations for Cancer ⬇️

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment

Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors

Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability

Role of LAG-3 in regulatory T cells.

Role of Stat3 in regulating p53 expression and function

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer ⬇️

Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype

Stat3 activation in murine colitis induced by enterotoxigenic Bacteroides fragilis

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens

Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab

T cells take aim at cancer

TCR β chain-directed bispecific antibodies for the treatment of T cell cancers

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity ⬇️

Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy

The Immunosuppressive Niche of Soft Tissue Sarcomas is Sustained by Tumor Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures

The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell Carcinoma

The blockade of immune checkpoints in cancer immunotherapy ⬇️

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints

Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy.

Treg functional stability and its responsiveness to the microenvironment

Ubiquitin-dependent regulation of Foxp3 and Treg function